<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01151943</url>
  </required_header>
  <id_info>
    <org_study_id>2010/15</org_study_id>
    <secondary_id>2010-019662-88</secondary_id>
    <nct_id>NCT01151943</nct_id>
  </id_info>
  <brief_title>Comparison of Two Types of Pain Relief After Cesarean Delivery</brief_title>
  <acronym>Cesar-Dol</acronym>
  <official_title>Comparison of Two Methods of Pain Relief After Cesarean Delivery: Transversus Abdominis Plane (TAP) Block Versus Incisional Infiltration With Local Anesthetic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women undergoing elective cesarean delivery, performed under a standard spinal anesthesia,
      will be randomized to undergo either TAP block or incisional infiltration with local
      anesthetic, in addition to standard postoperative analgesia comprising regular acetaminophen,
      nefopam and ketoprofen. Short acting oral morphine will be given as a rescue treatment in
      case of severe pain.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study has been halted prematurely beacuse of the occurence of convulsions in one case after
    TAP block.
  </why_stopped>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>severity of postoperative pain</measure>
    <time_frame>48 postoperative hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>delay before the first rescue dose of morphine</measure>
    <time_frame>48 postoperative hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morphine requirement</measure>
    <time_frame>48 postoperative hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication of each loco-regional technique</measure>
    <time_frame>end of hospitalisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient's satisfaction</measure>
    <time_frame>end of hospitalisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>end of hospitalisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of a neuropathic postoperative pain</measure>
    <time_frame>1 month postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">77</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Transversus Abdominis Plane (TAP) Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive a bilateral transversus abdominis plane block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Incisional Infiltration of Local Anesthetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive an incisional infiltration with local anesthetic (continuous administration of levobupivacaïne during 48 hours)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transversus Abdominis Plane (TAP) Block</intervention_name>
    <description>Bilateral injection of levobupivacaine (20 mL, 3.75 mg/mL)</description>
    <arm_group_label>Transversus Abdominis Plane (TAP) Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Incisional Infiltration of Local Anesthetic</intervention_name>
    <description>continuous administration of levobupivacaine (1,25 mg/mL,5 mL/h) during 48 hours.</description>
    <arm_group_label>Incisional Infiltration of Local Anesthetic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled cesarean section performed under spinal anesthesia

          -  ASA I or II

          -  height above 1,55 m

          -  singleton pregnancy

        Exclusion Criteria:

          -  contre indication to a drug used in the study (levobupivacaine, ketoprofen, nefopam)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Fischler, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Foch</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2010</study_first_submitted>
  <study_first_submitted_qc>June 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2010</study_first_posted>
  <last_update_submitted>November 2, 2016</last_update_submitted>
  <last_update_submitted_qc>November 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>continuous wound infiltration</keyword>
  <keyword>transversus abdominis plane block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

